Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Paul Grossman, Christine Meda

Premium

Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner. Grossman previously was head of global strategy and corporate development at Life Tech, and he also held the same position at Invitrogen. Before he joined Invitrogen, Grossman held various leadership roles at Applied Biosystems, including as a research scientist and patent attorney, VP of intellectual property, and VP of strategy and business development.


IncellDx has hired healthcare industry veteran Christine Meda as its chief business officer. In this role, she will be in charge of partnering with drug developers to drive adoption of IncellDx's Cellular Multiplexing technology, which gauges proteomic and genomic markers in a single assay.

Previously, Meda was president of Response Genetics and VP of women's health at Roche Molecular Diagnostics, and director of scientific affairs at Schering AG.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.